Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
6.91
+1.05 (17.92%)
At close: Apr 9, 2026, 4:00 PM EDT
6.95
+0.04 (0.58%)
After-hours: Apr 9, 2026, 5:30 PM EDT
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $1.8 billion as of April 9, 2026. Its market cap has decreased by -54.51% in one year.
Market Cap
1.80B
Enterprise Value
9.98B
1-Year Change
-54.51%
Ranking
Category
Stock Price
$6.91
Market Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $1.80B, a decrease of -78.63%. That is a compound annual growth rate of -27.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 1.53B | -18.17% |
| Dec 31, 2025 | 1.86B | -51.49% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
| May 14, 2021 | 8.42B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pfizer | 154.15B |
| Bristol-Myers Squibb Company | 117.75B |
| Sanofi | 112.50B |
| GSK plc | 111.00B |
| Biogen | 25.77B |
| Grifols | 6.49B |
| Amarin Corporation | 305.61M |
| MIRA Pharmaceuticals | 43.28M |